首页|重组人干扰素α-2b凝胶对宫颈鳞状上皮内病变人乳头瘤病毒感染患者免疫功能及阴道微生态恢复情况的影响

重组人干扰素α-2b凝胶对宫颈鳞状上皮内病变人乳头瘤病毒感染患者免疫功能及阴道微生态恢复情况的影响

扫码查看
目的 探讨宫颈鳞状上皮内病变人乳头瘤病毒(HPV)感染患者应用重组人干扰素α-2b凝胶治疗的临床效果.方法 选取2020 年2 月至2023 年2 月丽水市妇幼保健院收治的 116 例宫颈鳞状上皮内病变HPV感染患者作为研究对象.采用随机数字表法将其分为A组和B组,每组 58 例.A组给予聚甲酚磺醛栓,B组在A组基础上给予重组人干扰素α-2b凝胶.比较两组治疗 3 个月后的临床疗效、阴道微生态恢复情况,治疗前、治疗 3 个月后的免疫功能、C-反应蛋白(CRP)、Toll 样受体 2(TLR2)、白介素-17(IL-17)、转化生长因子-β(TGF-β)、干扰素-γ(IFN-γ)水平.结果 治疗 3 个月后,B组总有效率高于A组(P<0.05).治疗 3 个月后,两组的外周血CD3+、CD4+水平均比治疗前高,且B组大于A组(P<0.05);两组外周血CD8+、辅助性T细胞 17(Th17)、调节性T细胞(Treg)、Th17/Treg水平均比治疗前低,且B组低于A组(P<0.05).治疗3 个月后,B组阴道微生态正常或恢复及乳酸杆菌中量或大量的患者占比均高于A组,B组阴道pH低于A组(P<0.05).治疗3 个月后,两组血清TLR2、CRP、TGF-β、IL-17、IFN-γ水平均低于治疗前,且B组小于A组(P<0.05).结论 宫颈鳞状上皮内病变HPV感染患者应用重组人干扰素α-2b凝胶治疗可有效促进阴道微生态恢复,调节相关因子水平,减轻炎症反应,改善免疫功能,提高治疗效果.
Effects of recombinant human interferon α-2b gel on immune function and vaginal microecological recovery condition in cervical squamous intraepithelial lesions patients with human papilloma virus infection
Objective To explore the clinical effect of recombinant human interferon α-2b gel in cervical squamous intraepithelial lesions patients with human papilloma virus(HPV).Methods A total of 116 cervical squamous intraepithelial lesions patients with HPV infection admitted to Lishui Maternal and Child Health Hospital from February 2020 to February 2023 were selected as the research subjects.They were divided into the group A and the group B by random number table method,with 58 cases in each group.The group A was given policresulen suppositories,and the group B was given recombinant human interferon α-2b gel based on the group A.The clinical efficacy,vaginal microecological recovery condition after 3 months of treatment,immune function,C-reactive protein(CRP),Toll-like receptor 2(TLR2),interleukin-17(IL-17),transforming growth factor-β(TGF-β)and interferon-γ(IFN-γ)levels before and after 3 months of treatment were compared between the two groups.Results After 3 months of treatment,the total effective rate of group B was higher than the group A(P<0.05).After 3 months of treatment,the levels of peripheral blood cluster of differentiation 3+(CD3+)and CD4+in both groups were higher than before treatment,and the group B was higher than the group A.The levels of peripheral blood CD8+,helper T cell 17(Th17),regulatory T cell(Treg)and Th17/Treg in both groups were lower than before treatment,and the group B was lower than the group A(P<0.05).After 3 months of treatment,the proportion of patients in the group B with normal or recovered vaginal microecology and lactobacillus with medium/large quantities were higher than the group A,and the vaginal pH in the group B was lower than that in the group A(P<0.05).After 3 months of treatment,the levels of serum TLR2,CRP,TGF-β,IL-17,IFN-γin both groups were lower than before treatment,and the group B was lower than the group A(P<0.05).Conclusions Treatment with recombinant human interferon α-2b gel can effectively promote the recovery of vaginal microecology,regulate the levels of related factors,reduce inflammatory reaction,improve immune function,and improve the therapeutic effect in cervical squamous intraepithelial lesions patients with HPV.

Cervical squamous intraepithelial lesionsHuman papilloma virusRecombinant human interferon α-2b gel

何爱美、吴继现、程晓燕

展开 >

丽水市妇幼保健院妇女保健科,浙江 丽水 323000

丽水市妇幼保健院内科,浙江 丽水 323000

丽水市妇幼保健院妇科,浙江 丽水 323000

宫颈鳞状上皮内病变 人乳头瘤病毒 重组人干扰素α-2b凝胶

浙江省卫生健康委项目

2021KY1247

2024

中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
年,卷(期):2024.33(2)
  • 18